Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TCRT

Alaunos Therapeutics (TCRT)

Alaunos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TCRT
DateTimeSourceHeadlineSymbolCompany
29/02/202413:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
23/02/202408:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
21/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
15/02/202404:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202408:58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
30/01/202400:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
24/01/202409:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
23/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
04/01/202409:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
04/01/202409:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
03/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
29/12/202308:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
23/12/202300:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
15/11/202323:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202323:30GlobeNewswire Inc.Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
29/09/202306:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
06/09/202307:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
02/09/202302:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
15/08/202306:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRTAlaunos Therapeutics Inc
15/08/202306:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
15/08/202306:05GlobeNewswire Inc.Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
29/06/202321:00GlobeNewswire Inc.Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesNASDAQ:TCRTAlaunos Therapeutics Inc
13/06/202306:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRTAlaunos Therapeutics Inc
09/06/202307:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
09/06/202307:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
26/05/202307:00GlobeNewswire Inc.Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202321:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202321:00GlobeNewswire Inc.Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
03/05/202322:30GlobeNewswire Inc.Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
27/04/202302:30GlobeNewswire Inc.Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRT